Proceedings: Effect of nicotine and nicotine monomethiodide on vascular adrenergic neuroeffector transmission.
D000818:Animals; D001011:Aorta / Q000378:metabolism; D001949:Bretylium Compounds / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004558:Electric Stimulation; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D007455:Iodine / Q000494:pharmacology; D009411:Nerve Endings / Q000378:metabolism; D009538:Nicotine / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism; D011651:Pulmonary Artery / Q000294:innervation*; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects*; D014316:Tritium; D014403:Tubocurarine / Q000494:pharmacology; D014439:Tyramine / Q000037:antagonists & inhibitors / Q000494:pharmacology
D001949:Bretylium Compounds; D006584:Hexamethonium Compounds; D014316:Tritium; D009538:Nicotine; D007455:Iodine; D003042:Cocaine; D014403:Tubocurarine; D009638:Norepinephrine; D014439:Tyramine